Emily Milton[edit]

Emily Milton
DBE CVO FACP FRS
Emily Milton DBE CVO FACP FRS
	File:Dean Milton before a giving a lecture at Princeton University in 2048 Professor Milton before giving a lecture at Princeton University in 2048
Born	28 April 2001; Tulsa, Oklahoma
Awards	Nobel Prize in Physiology or Medicine (2062)
Academic background
Education	Holland Hall School
Alma mater	Hamilton College (BA) London School of Hygiene and Tropical Medicine (MSc) Harvard University (MPH, PhD, MD)
Academic work
Institutions	David Geffen School of Medicine, University of California, Los Angeles

Emily Ann Milton DBE CVO FACP FRS (born 28 April 2001) is an American physician, biochemist, public health expert and Dean of the David Geffen School Medicine at the University of California, Los Angeles (UCLA). She is most widely known for her extensive research into the nature of disease expansion and rates of cellular corruption in artificially augmented pluripotent cells, and for developing new procedural standards for the practice of clinical medicine in remote areas. Milton graduated from Holland Hall School in Tulsa, Oklahoma in 2019, and matriculated at Hamilton College, in Clinton, New York, graduating summa cum laude with a degree in Biology and Chemistry in 2023. She was selected as a Marshall Scholar, and attended the London School of Hygiene and Tropical Medicine, taking a Master of Science in Medical Microbiology after two years. She then attended Harvard University, where she took her Doctor of Medicine from Harvard Medical School, her Masters of Public Health from the Harvard T.H. Chan School of Public Health, and her Doctor of Philosophy in Biological Sciences in Public Health from the Graduate School of Arts and Sciences.

After graduating from medical school, Milton completed her residence at the Massachusetts General Hospital in Boston, Massachusetts, and was inducted as a Fellow of the American College of Physicians in 2033. Milton then joined Médecins Sans Frontières in 2033 as a public health consultant, and worked in Iraq, Pakistan, Venezuela and Guatemala. Milton left Médecins Sans Frontières in 2038, and took a teaching position at Georgetown University, while serving as a researcher at the National Institutes of Health. She then moved to the University of Chicago in 2042, where she remained for four more years, after which she was appointed Director of the Infectious Diseases Division at Emory University School of Medicine. While at Emory, Milton often worked as a consultant for the Centers for Disease Control and Prevention, also located in Atlanta.

In 2051, Milton was selected as Chair of the Biological Chemistry Department at the David Geffen School of Medicine at the University of California, Los Angeles. It was at UCLA that Milton published her groundbreaking research paper Notes on Advanced Medical Practices in Developing Nations in 2054, which garnered her the 2055 Wolf Prize in Medicine. In 2060, she was elevated to the position of Dean of the David Geffen School of Medicine, and was awarded both the Presidential Medal of Freedom and the Albert Lasker Special Achievement Award. In 2061, Milton was selected to receive the Nobel Prize in Physiology or Medicine, for "her work in the advancement of the use of biochemical sciences in public health,".

Milton was appointed an honorary Commander of the Royal Victorian Order in 2056, and an honorary Dame Commander of the Order of the British Empire in 2059. She was inducted as a Fellow of the Royal Society in 2048.